...
首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Comparison of intracoronary versus intravenous adenosine‐induced maximal hyperemia for fractional flow reserve measurement: A systematic review and meta‐analysis
【24h】

Comparison of intracoronary versus intravenous adenosine‐induced maximal hyperemia for fractional flow reserve measurement: A systematic review and meta‐analysis

机译:颅内肾上腺素腺苷诱导的最大高血压性分数流量储备测量的比较:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例

摘要

Abstract Objective We sought to perform a systematic review and meta‐analysis of the available literature comparing fractional flow reserve (FFR) measurements after administration of adenosine using intracoronary (IC) bolus versus standard continuous intravenous (IV) infusion. Background FFR is considered the gold standard for invasive assessment of coronary lesions of intermediate severity. IV adenosine is recommended to induce hyperemia; however, IC adenosine is widely used for convenience. The difference between IV and IC administration in lesions assessment is not well studied. Methods We systematically searched MEDLINE and relevant databases for studies comparing IV with IC adenosine administration for FFR measurement. We reviewed data pertaining to adenosine doses, side effects, and FFR values. Results Eight studies addressing the primary question were identified. Dose of IC adenosine varied between 36 and 600?μg. Compared to IV adenosine infusion, the sensitivity of IC administration is 0.805 (95% confidence interval [95% CI]: 0.664–0.896; p ??.001), specificity is 0.965 (95% CI: 0.932–0.983; p ??.001), positive likelihood ratio is 24.218 (95% CI: 12,263–47.830; p ??.001), negative likelihood ratio is 0.117 (95% CI: 0.033–0.411; p ??.01), and diagnostic odds ratio is 274.225 [95% CI: 92.731–810.946; p ??.001]. Overall, hemodynamic side effects and symptoms were reported more frequently with IV adenosine. Conclusions The available literature suggests that IC adenosine is well tolerated and may provide equivalent diagnostic accuracy compared to IV administration. However, variability in dosing regimens does not allow definitive conclusions regarding noninferiority of IC approach compared to IV administration.
机译:摘要目的我们寻求对可用文献进行系统审查和荟萃分析,比较使用Intracoronary(IC)推注施用腺苷与标准连续静脉内(IV)输注施用腺苷后的分数流量储备(FFR)测量。背景FFR被认为是中间严重程度冠状动脉病变的侵袭评估的金标准。静脉腺苷建议诱发充血;然而,IC腺苷广泛用于方便。病灶评估中IV和IC管理之间的差异并未得到很好的研究。方法我们系统地搜索了Medline和相关数据库,以进行研究与IC腺苷给予FFR测量的研究。我们审查了与腺苷剂量,副作用和FFR值有关的数据。结果确定了解决初级问题的八项研究。 IC腺苷的剂量在36到600℃之间变化。μg。与IV腺苷输注相比,IC施用的敏感性为0.805(95%置信区间[95%CI]:0.664-0.896;p≤00.001),特异性为0.965(95%CI:0.932-0.983; P; P ?& 001),阳性似然比为24.218(95%CI:12,2,263-47.830; p?+。001),负似然比为0.117(95%CI:0.033-0.411; p?p? .01),诊断赔率比例为274.225 [95%CI:92.731-810.946; p?& 001]。总体而言,血液动力学副作用和症状更频繁地呈现静脉腺苷。结论可用文献表明IC腺苷具有良好耐受性,与IV给药相比,可以提供等效的诊断准确度。然而,与IV局给药相比,给药方案的可变性不允许关于IC方法的非流体的结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号